TABLE 3.
Metabolic parameters.
CC | HC | CH | HH | CC + GH | HC + GH | CH + GH | HH + GH | |
IPGTT AUC | 1,657 ± 66 | 1,586 ± 77 | 2,808 ± 231 ****,#### | 2,133 ± 102 *,§§,‡‡‡ | 1,653 ± 109 | 1,585 ± 59 | 2,754 ± 144 | 2,408 ± 93 |
Glucose (mmol/L) | 11.89 ± 0.80 | 12.65 ± 1.09 | 14.95 ± 0.92 * | 16.37 ± 1.50 **,§§ | 13.27 ± 0.66 | 11.61 ± 0.72 | 14.26 ± 0.67 | 14.19 ± 1.08 |
Serum insulin (ng/mL) | 0.50 ± 0.14 | 0.25 ± 0.05 | 2.99 ± 0.91 *,## | 2.66 ± 0.42 *,§ | 0.40 ± 0.13 | 0.30 ± 0.06 | 3.64 ± 1.10 | 3.75 ± 1.41 |
HOMA-IR | 6.21 ± 1.48 | 3.41 ± 1.01 | 52.53 ± 16.28 **,## | 45.00 ± 9.21 *,§ | 5.27 ± 1.92 | 3.57 ± 0.94 | 50.30 ± 10.35 | 47.16 ± 27.10 |
Serum triglycerides (mg/mL) | 0.49 ± 0.04 | 0.48 ± 0.07 | 0.60 ± 0.03 | 0.73 ± 0.06 **,§§ | 0.58 ± 0.02 | 0.56 ± 0.07 | 0.73 ± 0.07 | 0.52 ± 0.04 ∧∧ |
NEFA (mmol/L) | 0.62 ± 0.07 | 0.65 ± 0.05 | 0.81 ± 0.07 | 0.90 ± 0.09 *,§ | 0.74 ± 0.10 | 0.85 ± 0.12 | 0.92 ± 0.09 | 0.72 ± 0.10 |
Urinary ACR (μg/mg) | 8.15 ± 2.30 | 23.89 ± 8.28 * | 24.66 ± 4.87 * | 41.38 ± 5.76 ****,§,‡ | 11.92 ± 2.67 | 14.65 ± 3.14 | 13.85 ± 2.75 | 18.82 ± 4.69 ∧∧ |
Serum creatinine (μmol/L) | 81.20 ± 16.12 | 58.15 ± 16.93 | 73.07 ± 10.02 | 185.00 ± 42.12 ***,§§§§,‡‡‡ | 66.83 ± 12.68 | 69.37 ± 17.19 | 96.23 ± 20.78 | 62.67 ± 9.19 ∧∧∧∧ |
Results expressed as mean ± SEM.
Compared with CC: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
HC vs. CH: ##p < 0.01, ####p < 0.0001.
HC vs. HH: § p < 0.05, §§ p < 0.01, §§§§ p < 0.0001.
CH vs. HH: ‡p < 0.05, ‡ ‡ ‡p < 0.001.
HH vs. HH + GH: ∧∧p < 0.01, ∧∧∧∧p < 0.0001.
IPGTT AUC, intraperitoneal glucose tolerance test area under the curve; HOMA-IR, homeostatic model assessment for insulin resistance; NEFA, non-esterified fatty acids; ACR, albumin:creatinine ratio.